Aztreonam + avibactam injection has attracted significant attention in the treatment of serious Gram-negative bacterial infections, particularly where antimicrobial resistance limits conventional treatment options. The combination brings together two complementary components: aztreonam, a monobactam antibacterial, and avibactam, a β-lactamase inhibitor. While the pharmacological rationale behind the combination is important, clinical evidence is equally important when...Read More